Flagship explainer
What drives BIOLARGO, INC.’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| −$15.2M | FY2025 |
| |
| Income before tax | −$15.2M | FY2025 |
|
| Operating income | −$14.9M | FY2025 |
|
| $7.8M | FY2025 |
| |
| Ending assets | $8.3M | FY2025 |
|
| Beginning assets | $10.5M | FY2024 |
|
| $4M | FY2025 |
| |
| $8.9M | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001437749-25-010172
- SEC filingFiling detailsAccession 0001437749-26-006926